Ken Griffin’s Avalyn Pharma AVLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$27.3M Buy
959,319
+221
+0% +$7.13K ﹤0.01% 2227
2026
Q2
$31.6M Buy
+959,098
New +$27.7M ﹤0.01% 2032

Other funds holding AVLN

Ken Griffin's AVLN Position: Q3 2026 in Review

Ken Griffin increased its Avalyn Pharma (AVLN) stake by 0.02% in Q3 2026, buying an estimated $7.13K and bringing the position to 959,319 shares worth $27.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2227.

Ken Griffin first reported a position in AVLN in Q2 2026 and has held it in 2 quarters since. The position peaked at $31.6M in Q2 2026. 116 funds tracked by Wall St. Rank hold AVLN as of Q3 2026.

  • Ken Griffin held 959,319 shares of Avalyn Pharma worth $27.3M as of Q3 2026.
  • Ken Griffin bought 221 Avalyn Pharma shares in Q3 2026, an estimated $7.13K.
  • Avalyn Pharma made up ﹤0.01% of Ken Griffin's portfolio in Q3 2026, its #2227 holding.
  • Ken Griffin first reported a position in Avalyn Pharma in Q2 2026 and has held it in 2 quarters since.
  • Ken Griffin's Avalyn Pharma position peaked at $31.6M in Q2 2026.
  • 116 funds tracked by Wall St. Rank held Avalyn Pharma as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.